| Items 161 ~ 180 of 25816, Page 9 of 1292 |
| 161. |
Novel Technique May Significantly Reduce Breast Biopsies - 12/11/2018
Radiological Society of North America |
| |
A combination of three-compartment breast image analysis and radiomics may improve cancer diagnosis and reduce breast biopsies... |
| 162. |
Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency¡¯s biosimilars policy framework - 12/11/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 163. |
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications - 12/11/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 164. |
Digital Mammography Increases Breast Cancer Detection - 12/11/2018
Radiological Society of North America |
| |
Digital mammography increased cancer detection by an overall rate of 14 percent in a large UK study... |
| 165. |
Abbott to Present at J.P. Morgan Healthcare Conference - 12/11/2018
Abbott |
| |
ABBOTT PARK, Ill., Dec. 11, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president of finance and Chief Financial Officer, will present at the conference at 11 a.m. Central time. |
| 166. |
Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs - 12/10/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 167. |
FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs - 12/10/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 168. |
New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer - 12/10/2018
American Cancer Society |
| |
Study compares Kadcyla (T-DM1) to Herceptin (Trastuzumab) |
| 169. |
Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data - 12/10/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 170. |
Merck¡¯s President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer and Michael Nally Named Chief Marketing Officer - 12/10/2018
MERCK |
| 171. |
Medtronic Named One of America''s Best Corporate Citizens in 2018 by Forbes Magazine - 12/10/2018
Medtronic |
| |
DUBLIN - December 10, 2018 -?Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America''s Most JUST Companies in 2018, according to?Forbes?magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st?on this year''s JUST 100: America''s Best Corporate Citizens list for outperforming its peers in areas such as fair treatment of employees, job creation, customer treatment, and product quality. |
| 172. |
American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Care - 12/10/2018
American Academy of Ophthalmology |
| |
Nation¡¯s eye physicians and surgeons support executive branch¡¯s emphasis on patient safety as state lawmakers weigh scope-of-practice expansion |
| 173. |
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019 - 12/07/2018
Medtronic |
| |
DUBLIN - December 7, 2018 -?The board of directors of?Medtronic?plc?(NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years. The dividend is payable on January 18, 2019, to shareholders of record at the close of business on December 28, 2018. |
| 174. |
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA¡¯s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products - 12/06/2018
U.S. FOOD & DRUG ADMINISTRATION |
| |
One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled. |
| 175. |
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA¡¯s new strategic framework to advance use of real-world evidence to support development of drugs and biologics - 12/06/2018
U.S. FOOD & DRUG ADMINISTRATION |
| 176. |
FDA Approves First Biosimilar for Non-Hodgkin Lymphoma - 12/06/2018
American Cancer Society |
| |
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma. |
| 177. |
Decline Stalls: 58 Million Americans Still Exposed to Secondhand Smoke - 12/06/2018
Centers for Disease Control and Prevention |
| |
Exposure remains high for certain groups, including kids |
| 178. |
AAOS Encouraged by Administration¡¯s Plan to Promote Healthcare Competition - 12/06/2018
American Academy of Orthopaedic Surgeons |
| 179. |
Health benefits far outweigh the costs of meeting climate change goals - 12/05/2018
WHO |
| 180. |
FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care - 12/04/2018
U.S. FOOD & DRUG ADMINISTRATION |
